Three Months versus One Year of Oral Anticoagulant Therapy for Idiopathic Deep Venous Thrombosis
Giancarlo Agnelli(University of Perugia), Walter Ageno(University of Padua), Gualtiero Palareti(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola), Roberto Parisi, Adriano Alatri, Maria Gabriella Santamaria(University of Perugia), Mauro Silingardi(Ospedale Maggiore Carlo Alberto Pizzardi), A Vaccarino(Istituto di Ematologia di Bologna), Paola Bagatella(University of Padua), Paolo Prandoni(University of Padua), Alfonso Iorio(Impact), Antonio Girolami(Amsterdam UMC Location University of Amsterdam), Giuliana Guazzaloca(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola), Laura Mosena, Alessandra Ascani, Silvia Maria da Silva Doria, Adriano Bertoldi(Ospedale Santa Chiara), Mario Marchesi(Ospedale Maggiore), Luigi Steidl, Cristina Tomasi(Ospedale di Bolzano), Marco Moia(Ospedale Maggiore), Michela Frulla, Ido Iori, Giovanni B. Ambrosio, Gianluigi Scannapieco, Mario Bazzan(Ospedale San Giovanni Bosco), Fabio Ambrosini, Angelo Ghirarduzzi(University of Padua), Sabina Villalta(Ca' Foncello Hospital)
Cited by 599
Related Papers
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
|Journal of the American College of Cardiology|2020|2.9k
Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis
|Blood|2002|1.9k
Oral Anticoagulant Therapy
|CHEST Journal|2012|1.5k
American Society of Hematology 2020 Guidelines for Management of Venous Thromboembolism: Treatment of Deep Vein Thrombosis and Pulmonary Embolism
|Blood Advances|2020|1.4k
A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score
|Journal of Thrombosis and Haemostasis|2010|1.2k